Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine and Fluoxetine in Bipolar Depression
NCT00191399Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of olanzapine, fluoxetine in bipolar disorder (BD), sponsored by Eli Lilly and Company. Started May 2004; status: completed.
02
Drugs
olanzapinefluoxetine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00191399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191399.